A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help ...

A study from Emory University suggests that levodopa, a medication that increases dopamine levels in the brain, may help treat individuals with ...

Only 1 participant in each cohort reached the primary outcome, which was a 50% or greater improvement in BFMDR score. Levodopa did not show a significant benefit in reducing dystonia, disability, or ...

Despite being a mainstay of Parkinson's disease treatment, levodopa, a dopamine-replenishing medication, can cause nasty side ...

Despite past failures, Denali's extensive pipeline and solid financial runway make it a compelling buy at current low stock ...

Q4 2024 Earnings Conference Call March 20, 2025 8:30 AM ET. Company Participants. Samira Sakhia - President and Chief Executive Officer Arvi ...

Reports record-high revenues since inceptionMONTREAL, March 20, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty ...

With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than two-thirds of people with Parkinson's disease live with chronic pain, which ...

AbbVie has launched its Produodopa therapy for Parkinson’s disease onto the market in the EU, becoming the first and only 24-hour levodopa-based subcutaneous infusion therapy for the ...

Medically reviewed by Smita Patel, DO Bradykinesia is a progressive movement symptom commonly found in people with ...

Scientists from the University of Rochester and other institutions have found new evidence that a common industrial chemical, ...